Membranous Nephropathy
Authors:
- Tatiana T. AntonovychTATatiana T. Antonovych
- Karen MacKayKMKaren MacKay
- Dimitrios T. BoumpasDBDimitrios T. Boumpas
- James E. BalowJBJames E. Balow
- 15 April 1992
- journal article
- Published by American College of Physicians in Annals of Internal Medicine
- Vol. 116 (8) , 672-682
Abstract
Membranous nephropathy is a worldwide problem that accounts for about 20% of the cases of the adult-onset nephrotic syndrome. This disease places many patients at risk for both end-stage renal failure and the complications of hyperlipidemia. Immune-mediated injury to the glomerular capillary wall in patients with membranous nephropathy is characterized by subepithelial immune complex formation and generation of the membrane attack complex of complement. Glomerular capillary hypertension, hyperlipidemia, and possibly cytokines could contribute to the glomerular sclerosis seen in the advanced stages of the disorder. In some cases, production of pathogenic antibody can be suppressed by treating the underlying condition. The mechanisms of action of immunosuppressive agents are being investigated and treatments are being tested in clinical trials to optimize the balance of efficacy and toxicity. Alternate-day treatment with corticosteroids is often recommended for nephrotic patients with idiopathic membranous nephropathy, but this approach has not been proved beneficial. Ongoing studies are evaluating whether cytotoxic drugs or cyclosporin A combined with prednisone is more effective than treatment with corticosteroids alone. Lipid-lowering drug therapy is warranted in cases of the persistent nephrotic syndrome to avert the cardiovascular sequelae of hyperlipidemia.Keywords
This publication has 80 references indexed in Scilit:
- Cholesterol and Coronary Heart DiseaseJAMA, 1990
- Lipoproteins and AtherogenesisJAMA, 1990
- The actions of cyclosporin A and FK506 suggest a novel step in the activation of T lymphocytes.The EMBO Journal, 1990
- Transcriptional interference between c-Jun and the glucocorticoid receptor: Mutual inhibition of DNA binding due to direct protein-protein interactionCell, 1990
- The pathogenesis of membranous glomerulonephritis from morphology to moleculesVirchows Archiv B Cell Pathology Including Molecular Pathology, 1989
- Gene regulation by steroid hormonesCell, 1989
- Relationship between corticosteroid exposure and plasma lipid levels in heart transplant recipientsThe American Journal of Medicine, 1988
- Long-term prognosis of idiopathic membranous glomerulonephritisThe American Journal of Medicine, 1979
- Status of the coronary arteries in the nephrotic syndromeThe American Journal of Medicine, 1977
- Nephropathy of Secondary SyphilisJAMA, 1971